Chemical Component Summary | |
---|---|
Name | 2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxyphenyl)benzenesulfonamide |
Identifiers | 2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxy-phenyl)benzenesulfonamide |
Formula | C13 H7 F6 N O3 S |
Molecular Weight | 371.255 |
Type | NON-POLYMER |
Isomeric SMILES | COc1ccc(cc1F)NS(=O)(=O)c2c(c(c(c(c2F)F)F)F)F |
InChI | InChI=1S/C13H7F6NO3S/c1-23-7-3-2-5(4-6(7)14)20-24(21,22)13-11(18)9(16)8(15)10(17)12(13)19/h2-4,20H,1H3 |
InChIKey | ROZCIVXTLACYNY-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 31 |
Chiral Atom Count | 0 |
Bond Count | 32 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB16103 |
---|---|
Name | Batabulin |
Groups | investigational |
Description | Batabulin is under investigation in clinical trial NCT00057382 (T138067 Versus Doxorubicin in Chemotherapy-naive, Unresectable, Hepatocellular Carcinoma Patients). |
Synonyms | Batabulin |
Categories |
|
CAS number | 195533-53-0 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 216324 |
ChEMBL | CHEMBL79280 |